Clinical Trials Browser

Terminated × Pharmacogenomic Variants × Other hematologic neoplasm × Clear all

NCT03557970 2021-12-02

JNJ-40346527 in Treating Participants With Relapsed or Refractory Acute Myeloid Leukemia

Phase 2 Terminated

3 enrolled 10 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute